This paper studies life-cycle preferences over consumption and health status. We show that cost-effectiveness analysis is consistent with cost-benefit analysis if the Lifetime utility function is additive over time, multiplicative in the utility of consumption and the utility of health status, and if the utility of consumption is constant over time. We derive the conditions under which the lifetime utility function takes this form, both under expected utility theory and under rank-dependent utility theory, which is currently the most important nonexpected utility theory. If cost-effectiveness analysis is consistent with cost-benefit analysis, it is possible to derive tractable expressions for the willingness to pay for quality-adjusted life...
The objective of this article is to examine how people value two different attributes of Value of Li...
Health resource allocation decisions increasingly use measures such as Quality Adjusted Life Years ...
AbstractObjectiveThe US Public Health Service Panel on Cost-Effectiveness has recommended the use of...
International audienceThe value of reducing health and mortality risks is often measured using value...
Despite the widespread use of quality-adjusted life years (QALY) in economic evaluation studies, the...
Despite the widespread use of quality-adjusted life years (QALY) in economic evaluation studies, the...
Most medical cost-effectiveness analyses include future costs only for related illnesses, but this a...
We design and conduct a stated-preference survey to test whether willingness to pay (WTP) to reduce ...
AbstractThe equivalence of cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) has bee...
Cost-benefit analysis (CBA) is a recognised as the economic evaluation technique that accords most w...
The cost-effectiveness of health care interventions is often evaluated using quality-adjusted life y...
We provide a structural theory of time preference and derive a functional form of intertemporal pref...
Cost-benefit analysis (CBA) provides a clear decision rule: undertake an intervention if the monetar...
This thesis studies the applicability of quality-adjusted life years (QALYs) and other utility base...
This paper investigates the relationship between saving and health spending in a two-period overlapp...
The objective of this article is to examine how people value two different attributes of Value of Li...
Health resource allocation decisions increasingly use measures such as Quality Adjusted Life Years ...
AbstractObjectiveThe US Public Health Service Panel on Cost-Effectiveness has recommended the use of...
International audienceThe value of reducing health and mortality risks is often measured using value...
Despite the widespread use of quality-adjusted life years (QALY) in economic evaluation studies, the...
Despite the widespread use of quality-adjusted life years (QALY) in economic evaluation studies, the...
Most medical cost-effectiveness analyses include future costs only for related illnesses, but this a...
We design and conduct a stated-preference survey to test whether willingness to pay (WTP) to reduce ...
AbstractThe equivalence of cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) has bee...
Cost-benefit analysis (CBA) is a recognised as the economic evaluation technique that accords most w...
The cost-effectiveness of health care interventions is often evaluated using quality-adjusted life y...
We provide a structural theory of time preference and derive a functional form of intertemporal pref...
Cost-benefit analysis (CBA) provides a clear decision rule: undertake an intervention if the monetar...
This thesis studies the applicability of quality-adjusted life years (QALYs) and other utility base...
This paper investigates the relationship between saving and health spending in a two-period overlapp...
The objective of this article is to examine how people value two different attributes of Value of Li...
Health resource allocation decisions increasingly use measures such as Quality Adjusted Life Years ...
AbstractObjectiveThe US Public Health Service Panel on Cost-Effectiveness has recommended the use of...